Wait, we have a special offer for you! ✋

Get your exclusive discount now

YES, get the discount! No, I'd pay the full price
Global Muscle Wasting Disorders Market Report 2024

Muscle Wasting Disorders Global Market Report 2024 – By Treatment Type (Medications, Physical Therapy, Nutritional Therapy, Surgery, Gene Therapy, Other Treatment Types), By Disorder Type (Muscular Dystrophy, Amyotrophic Lateral Sclerosis (ALS), Other Disorder Types), By End-User (Hospitals, Rehab Centers, Specialty Clinics, Other End-Users) – Market Size, Trends, And Global Forecast 2024-2033

Muscle Wasting Disorders Global Market Report 2024

Starting Price : $5000.00 | Pages : 175 | Published : March 2024 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options
Request Sample
Request For Discount
Customise Your Report
Request For Proposal
Request For Regional Data
FAQs

Need assistance or more information before the purchase?

Enquire Before Buying
Muscle Wasting Disorders Global Market Report 2024

Proud Members Of

checkslacipN checkaoirsN checkscipN
Description Table Of Contents Tables & Figures Market Insights Related Reports

Muscle Wasting Disorders Market Definition And Segments

Muscle wasting disorders, or muscle atrophy or muscle wasting, refer to a condition characterized by a diverse group of conditions that cause the progressive loss of muscle mass and strength. This can occur as a result of various factors, including disuse, aging, malnutrition, neurodegenerative diseases, and certain medical conditions.

The main treatments of muscle wasting disorders are medications, physical therapy, nutritional therapy, surgery, gene therapy, and others. Muscle wasting disorder medications refer to drugs that are used to treat conditions such as sarcopenia, cachexia, and muscular dystrophy. These medications aim to increase muscle mass and improve muscle function. They are used for the treatment of muscular dystrophy, amyotrophic lateral sclerosis (ALS), and others by hospitals, rehab centers, specialty clinics, and other end-users.

The muscle wasting disorders market covered in this report is segmented –

1) By Treatment Type: Medications, Physical Therapy, Nutritional Therapy, Surgery, Gene Therapy, Other Treatment Types

2) By Disorder Type: Muscular Dystrophy, Amyotrophic Lateral Sclerosis (ALS), Other Disorder Types

3) By End-User: Hospitals, Rehab Centers, Specialty Clinics, Other End-Users

The muscle wasting disorders market size has grown rapidly in recent years. It will grow from $12.91 billion in 2023 to $15.06 billion in 2024 at a compound annual growth rate (CAGR) of 16.6%. The growth in the historic period can be attributed to increasing aging population, rising incidence of chronic diseases, advancements in research and development, increased awareness of early diagnosis, emerging therapeutic approaches.

The muscle wasting disorders market size is expected to see rapid growth in the next few years. It will grow to $26.11 billion in 2028 at a compound annual growth rate (CAGR) of 14.8%. The growth in the forecast period can be attributed to regulatory support, patient advocacy initiatives, healthcare infrastructure development, globalization of clinical trials, personalized medicine approaches. Major trends in the forecast period include telemedicine adoption, technological advancements in diagnostics, product innovation, collaborations and partnerships, advancements in therapeutics, research on molecular mechanisms, biopharmaceutical innovation.

Sedentary Lifestyle Trends Fueling Growth In The Muscle Wasting Disorders Market

Rising adherence to a sedentary lifestyle is expected to propel the growth of the muscle wasting disorders market going forward. A sedentary lifestyle refers to a lifestyle in which an individual is physically inactive and engages in little or no physical movement or exercise. Sedentary behavior can negatively impact muscle function, leading to a decline in muscle strength and endurance, contributing to muscle wasting disorders, and making it more difficult for individuals to maintain their muscle mass and function. For instance, in 2022, according to the World Health Organization, a Switzerland-based intergovernmental organization, over 80% of adolescents and 27% of adults did not adhere to the physical activity levels recommended by the World Health Organization. Therefore, rising adherence to a sedentary lifestyle is driving the growth of the muscle wasting disorders market.

Major companies operating in the muscle wasting disorders market report are Pfizer Inc., F. Hoffmann-La Roche Ltd., Roche Holding AG, Novartis AG, Sanofi, GlaxoSmithKline (GSK), Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals, Acceleron Pharma Inc., Biogen Inc., Santhera Pharmaceuticals Holding AG, Mitsubishi Tanabe Pharma, Nippon Shinyaku Co. Ltd. (NS Pharma, Inc.), Sarepta Therapeutics Inc., PTC Therapeutics Inc., Ionis Pharmaceuticals Inc., Axogen, Inc., FibroGen Inc., Cytokinetics Incorporated, Italfarmaco S.p.A., Scholar Rock, Bellerophon Therapeutics, Akashi Therapeutics, aTyr Pharma, Metabolic Solutions Development Company, Synaptogenix, MyoKardia, Inc., MyoTherix Inc.

Innovative Advancements In The Muscle Wasting Disorders Market

Major companies operating in the muscle wasting disorders market are developing innovative products, such as novel gene therapy, to better serve patients with muscle wasting disorders. Novel gene therapy refers to a medical technology that aims to produce a therapeutic effect through the manipulation of gene expression or altering the biological properties of living cells. For instance, in June 2023, Sarepta Therapeutics, a US-based biotechnology company, introduced Elevidys, which is the first gene therapy approved by the U.S. Food and Drug Administration (FDA) for the treatment of Duchenne muscular dystrophy (DMD) in pediatric patients between the ages of 4 and 5 years old. Elevidys is a recombinant gene therapy designed to deliver into the body a gene that leads to a shortened protein that contains selected domains of the dystrophin protein of normal muscle cells. The product is administered as a single intravenous infusion.

Biogen Expands Rare Disease Portfolio through Acquisition of Reata Pharmaceuticals

In September 2023, Biogen Inc., a US-based biotechnology company, acquired Reata Pharmaceuticals Inc. for $7.3 billion. With the acquisition, Biogen is expected to bolster Biogen's rare disease portfolio with the addition of Friedreich's ataxia, which is a genetic, progressive, life-shortening, debilitating, and degenerative disease that affects the nervous system and muscles. Reata Pharmaceuticals Inc. is a US-based pharmaceutical company focused on developing therapeutics for neuromuscular disorders and muscle wasting disorders.

North America was the largest region in the muscle wasting disorder market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the muscle wasting disorders market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the muscle wasting disorders market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The muscle wasting disorders market consists of revenues earned by entities by providing services such as diagnostic services, medical services, support services and community services. The market value includes the value of related goods sold by the service provider or included within the service offering. The muscle wasting disorders market also includes sales of anabolic steroids, growth hormone, enobosarm and bimagrumab. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The muscle wasting disorders market research report is one of a series of new reports from The Business Research Company that provides muscle wasting disorders market statistics, including muscle wasting disorders industry global market size, regional shares, competitors with a muscle wasting disorders market share, detailed muscle wasting disorders market segments, market trends and opportunities, and any further data you may need to thrive in the muscle wasting disorders industry. This muscle wasting disorders market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Muscle Wasting Disorders Market Report Scope
Report AttributeDetails
Market Size Value In 2024 $15.06 billion
Revenue Forecast In 2033 $26.11 billion
Growth Rate CAGR of 14.8% from 2024 to 2033
Base Year For Estimation 2023
Actual Estimates/Historical Data 2018-2023
Forecast Period 2024 - 2028 - 2033
Market Representation Revenue in USD Billion and CAGR from 2024 to 2033
Segments Covered 1) By Treatment Type: Medications, Physical Therapy, Nutritional Therapy, Surgery, Gene Therapy, Other Treatment Types
2) By Disorder Type: Muscular Dystrophy, Amyotrophic Lateral Sclerosis (ALS), Other Disorder Types
3) By End-User: Hospitals, Rehab Centers, Specialty Clinics, Other End-Users
Regional Scope Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Country Scope Australia; China; India; Indonesia; Japan; South Korea; Bangladesh; Thailand; Vietnam; Malaysia; Singapore; Philippines; Hong Kong; New Zealand; USA; Canada; Mexico; Brazil; Chile; Argentina; Colombia; Peru; France; Germany; UK; Austria; Belgium; Denmark; Finland; Ireland; Italy; Netherlands; Norway; Portugal; Spain; Sweden; Switzerland; Russia; Czech Republic; Poland; Romania; Ukraine; Saudi Arabia; Israel; Iran; Turkey; UAE; Egypt; Nigeria; South Africa
Key Companies Profiled Pfizer Inc.; F. Hoffmann-La Roche Ltd.; Roche Holding AG; Novartis AG; Sanofi; GlaxoSmithKline (GSK); Eli Lilly and Company; Teva Pharmaceutical Industries Ltd.; Regeneron Pharmaceuticals; Acceleron Pharma Inc.; Biogen Inc.; Santhera Pharmaceuticals Holding AG; Mitsubishi Tanabe Pharma; Nippon Shinyaku Co. Ltd. (NS Pharma, Inc.); Sarepta Therapeutics Inc.; PTC Therapeutics Inc.; Ionis Pharmaceuticals Inc.; Axogen, Inc.; FibroGen Inc.; Cytokinetics Incorporated; Italfarmaco S.p.A.; Scholar Rock; Bellerophon Therapeutics; Akashi Therapeutics; aTyr Pharma; Metabolic Solutions Development Company; Synaptogenix; MyoKardia, Inc.; MyoTherix Inc.
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

    Table Of Contents

    1. Executive Summary

    2. Muscle Wasting Disorders Market Characteristics

    3. Muscle Wasting Disorders Market Trends And Strategies

    4. Muscle Wasting Disorders Market - Macro Economic Scenario

    4.1. Impact Of High Inflation On The Market

    4.2. Ukraine-Russia War Impact On The Market

    4.3. COVID-19 Impact On The Market

    5. Global Muscle Wasting Disorders Market Size and Growth

    5.1. Global Muscle Wasting Disorders Market Drivers and Restraints

    5.1.1. Drivers Of The Market

    5.1.2. Restraints Of The Market

    5.2. Global Muscle Wasting Disorders Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)

    5.3. Global Muscle Wasting Disorders Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

    6. Muscle Wasting Disorders Market Segmentation

    6.1. Global Muscle Wasting Disorders Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Medications

    Physical Therapy

    Nutritional Therapy

    Surgery

    Gene Therapy

    Other Treatment Types

    6.2. Global Muscle Wasting Disorders Market, Segmentation By Disorder Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Muscular Dystrophy

    Amyotrophic Lateral Sclerosis (ALS)

    Other Disorder Types

    6.3. Global Muscle Wasting Disorders Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Hospitals

    Rehab Centers

    Specialty Clinics

    Other End-Users

    7. Muscle Wasting Disorders Market Regional And Country Analysis

    7.1. Global Muscle Wasting Disorders Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    7.2. Global Muscle Wasting Disorders Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8. Asia-Pacific Muscle Wasting Disorders Market

    8.1. Asia-Pacific Muscle Wasting Disorders Market Overview

    Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Muscle Wasting Disorders Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8.3. Asia-Pacific Muscle Wasting Disorders Market, Segmentation By Disorder Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8.4. Asia-Pacific Muscle Wasting Disorders Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    9. China Muscle Wasting Disorders Market

    9.1. China Muscle Wasting Disorders Market Overview

    9.2. China Muscle Wasting Disorders Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    9.3. China Muscle Wasting Disorders Market, Segmentation By Disorder Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    9.4. China Muscle Wasting Disorders Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    10. India Muscle Wasting Disorders Market

    10.1. India Muscle Wasting Disorders Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    10.2. India Muscle Wasting Disorders Market, Segmentation By Disorder Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    10.3. India Muscle Wasting Disorders Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11. Japan Muscle Wasting Disorders Market

    11.1. Japan Muscle Wasting Disorders Market Overview

    11.2. Japan Muscle Wasting Disorders Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11.3. Japan Muscle Wasting Disorders Market, Segmentation By Disorder Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11.4. Japan Muscle Wasting Disorders Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12. Australia Muscle Wasting Disorders Market

    12.1. Australia Muscle Wasting Disorders Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12.2. Australia Muscle Wasting Disorders Market, Segmentation By Disorder Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12.3. Australia Muscle Wasting Disorders Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13. Indonesia Muscle Wasting Disorders Market

    13.1. Indonesia Muscle Wasting Disorders Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13.2. Indonesia Muscle Wasting Disorders Market, Segmentation By Disorder Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13.3. Indonesia Muscle Wasting Disorders Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14. South Korea Muscle Wasting Disorders Market

    14.1. South Korea Muscle Wasting Disorders Market Overview

    14.2. South Korea Muscle Wasting Disorders Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14.3. South Korea Muscle Wasting Disorders Market, Segmentation By Disorder Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14.4. South Korea Muscle Wasting Disorders Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15. Western Europe Muscle Wasting Disorders Market

    15.1. Western Europe Muscle Wasting Disorders Market Overview

    15.2. Western Europe Muscle Wasting Disorders Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15.3. Western Europe Muscle Wasting Disorders Market, Segmentation By Disorder Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15.4. Western Europe Muscle Wasting Disorders Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16. UK Muscle Wasting Disorders Market

    16.1. UK Muscle Wasting Disorders Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16.2. UK Muscle Wasting Disorders Market, Segmentation By Disorder Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16.3. UK Muscle Wasting Disorders Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17. Germany Muscle Wasting Disorders Market

    17.1. Germany Muscle Wasting Disorders Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17.2. Germany Muscle Wasting Disorders Market, Segmentation By Disorder Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17.3. Germany Muscle Wasting Disorders Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18. France Muscle Wasting Disorders Market

    18.1. France Muscle Wasting Disorders Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18.2. France Muscle Wasting Disorders Market, Segmentation By Disorder Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18.3. France Muscle Wasting Disorders Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19. Italy Muscle Wasting Disorders Market

    19.1. Italy Muscle Wasting Disorders Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19.2. Italy Muscle Wasting Disorders Market, Segmentation By Disorder Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19.3. Italy Muscle Wasting Disorders Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20. Spain Muscle Wasting Disorders Market

    20.1. Spain Muscle Wasting Disorders Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20.2. Spain Muscle Wasting Disorders Market, Segmentation By Disorder Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20.3. Spain Muscle Wasting Disorders Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21. Eastern Europe Muscle Wasting Disorders Market

    21.1. Eastern Europe Muscle Wasting Disorders Market Overview

    21.2. Eastern Europe Muscle Wasting Disorders Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21.3. Eastern Europe Muscle Wasting Disorders Market, Segmentation By Disorder Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21.4. Eastern Europe Muscle Wasting Disorders Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22. Russia Muscle Wasting Disorders Market

    22.1. Russia Muscle Wasting Disorders Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22.2. Russia Muscle Wasting Disorders Market, Segmentation By Disorder Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22.3. Russia Muscle Wasting Disorders Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23. North America Muscle Wasting Disorders Market

    23.1. North America Muscle Wasting Disorders Market Overview

    23.2. North America Muscle Wasting Disorders Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23.3. North America Muscle Wasting Disorders Market, Segmentation By Disorder Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23.4. North America Muscle Wasting Disorders Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24. USA Muscle Wasting Disorders Market

    24.1. USA Muscle Wasting Disorders Market Overview

    24.2. USA Muscle Wasting Disorders Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24.3. USA Muscle Wasting Disorders Market, Segmentation By Disorder Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24.4. USA Muscle Wasting Disorders Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25. Canada Muscle Wasting Disorders Market

    25.1. Canada Muscle Wasting Disorders Market Overview

    25.2. Canada Muscle Wasting Disorders Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25.3. Canada Muscle Wasting Disorders Market, Segmentation By Disorder Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25.4. Canada Muscle Wasting Disorders Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26. South America Muscle Wasting Disorders Market

    26.1. South America Muscle Wasting Disorders Market Overview

    26.2. South America Muscle Wasting Disorders Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26.3. South America Muscle Wasting Disorders Market, Segmentation By Disorder Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26.4. South America Muscle Wasting Disorders Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27. Brazil Muscle Wasting Disorders Market

    27.1. Brazil Muscle Wasting Disorders Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27.2. Brazil Muscle Wasting Disorders Market, Segmentation By Disorder Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27.3. Brazil Muscle Wasting Disorders Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28. Middle East Muscle Wasting Disorders Market

    28.1. Middle East Muscle Wasting Disorders Market Overview

    28.2. Middle East Muscle Wasting Disorders Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28.3. Middle East Muscle Wasting Disorders Market, Segmentation By Disorder Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28.4. Middle East Muscle Wasting Disorders Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29. Africa Muscle Wasting Disorders Market

    29.1. Africa Muscle Wasting Disorders Market Overview

    29.2. Africa Muscle Wasting Disorders Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29.3. Africa Muscle Wasting Disorders Market, Segmentation By Disorder Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29.4. Africa Muscle Wasting Disorders Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    30. Muscle Wasting Disorders Market Competitive Landscape And Company Profiles

    30.1. Muscle Wasting Disorders Market Competitive Landscape

    30.2. Muscle Wasting Disorders Market Company Profiles

    30.2.1. Pfizer Inc.

    30.2.1.1. Overview

    30.2.1.2. Products and Services

    30.2.1.3. Strategy

    30.2.1.4. Financial Performance

    30.2.2. F. Hoffmann-La Roche Ltd.

    30.2.2.1. Overview

    30.2.2.2. Products and Services

    30.2.2.3. Strategy

    30.2.2.4. Financial Performance

    30.2.3. Roche Holding AG

    30.2.3.1. Overview

    30.2.3.2. Products and Services

    30.2.3.3. Strategy

    30.2.3.4. Financial Performance

    30.2.4. Novartis AG

    30.2.4.1. Overview

    30.2.4.2. Products and Services

    30.2.4.3. Strategy

    30.2.4.4. Financial Performance

    30.2.5. Sanofi

    30.2.5.1. Overview

    30.2.5.2. Products and Services

    30.2.5.3. Strategy

    30.2.5.4. Financial Performance

    31. Muscle Wasting Disorders Market Other Major And Innovative Companies

    31.1. GlaxoSmithKline (GSK)

    31.2. Eli Lilly and Company

    31.3. Teva Pharmaceutical Industries Ltd.

    31.4. Regeneron Pharmaceuticals

    31.5. Acceleron Pharma Inc.

    31.6. Biogen Inc.

    31.7. Santhera Pharmaceuticals Holding AG

    31.8. Mitsubishi Tanabe Pharma

    31.9. Nippon Shinyaku Co. Ltd. (NS Pharma, Inc.)

    31.10. Sarepta Therapeutics Inc.

    31.11. PTC Therapeutics Inc.

    31.12. Ionis Pharmaceuticals Inc.

    31.13. Axogen, Inc.

    31.14. FibroGen Inc.

    31.15. Cytokinetics Incorporated

    32. Global Muscle Wasting Disorders Market Competitive Benchmarking

    33. Global Muscle Wasting Disorders Market Competitive Dashboard

    34. Key Mergers And Acquisitions In The Muscle Wasting Disorders Market

    35. Muscle Wasting Disorders Market Future Outlook and Potential Analysis

    35.1 Muscle Wasting Disorders Market In 2028 - Countries Offering Most New Opportunities

    35.2 Muscle Wasting Disorders Market In 2028 - Segments Offering Most New Opportunities

    35.3 Muscle Wasting Disorders Market In 2028 - Growth Strategies

    35.3.1 Market Trend Based Strategies

    35.3.2 Competitor Strategies

    36. Appendix

    36.1. Abbreviations

    36.2. Currencies

    36.3. Historic And Forecast Inflation Rates

    36.4. Research Inquiries

    36.5. The Business Research Company

    36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Table 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Table 3: Global Muscle Wasting Disorders Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 4: Global Muscle Wasting Disorders Market, Segmentation By Disorder Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 5: Global Muscle Wasting Disorders Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 6: Global Muscle Wasting Disorders Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 7: Global Muscle Wasting Disorders Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 8: Asia-Pacific, Muscle Wasting Disorders Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 9: Asia-Pacific, Muscle Wasting Disorders Market, Segmentation By Disorder Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 10: Asia-Pacific, Muscle Wasting Disorders Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 11: China, Muscle Wasting Disorders Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 12: China, Muscle Wasting Disorders Market, Segmentation By Disorder Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 13: China, Muscle Wasting Disorders Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 14: India, Muscle Wasting Disorders Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 15: India, Muscle Wasting Disorders Market, Segmentation By Disorder Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 16: India, Muscle Wasting Disorders Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 17: Japan, Muscle Wasting Disorders Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 18: Japan, Muscle Wasting Disorders Market, Segmentation By Disorder Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 19: Japan, Muscle Wasting Disorders Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 20: Australia, Muscle Wasting Disorders Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 21: Australia, Muscle Wasting Disorders Market, Segmentation By Disorder Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 22: Australia, Muscle Wasting Disorders Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 23: Indonesia, Muscle Wasting Disorders Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 24: Indonesia, Muscle Wasting Disorders Market, Segmentation By Disorder Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 25: Indonesia, Muscle Wasting Disorders Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 26: South Korea, Muscle Wasting Disorders Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 27: South Korea, Muscle Wasting Disorders Market, Segmentation By Disorder Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 28: South Korea, Muscle Wasting Disorders Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 29: Western Europe, Muscle Wasting Disorders Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 30: Western Europe, Muscle Wasting Disorders Market, Segmentation By Disorder Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 31: Western Europe, Muscle Wasting Disorders Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 32: UK, Muscle Wasting Disorders Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 33: UK, Muscle Wasting Disorders Market, Segmentation By Disorder Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 34: UK, Muscle Wasting Disorders Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 35: Germany, Muscle Wasting Disorders Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 36: Germany, Muscle Wasting Disorders Market, Segmentation By Disorder Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 37: Germany, Muscle Wasting Disorders Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 38: France, Muscle Wasting Disorders Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 39: France, Muscle Wasting Disorders Market, Segmentation By Disorder Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 40: France, Muscle Wasting Disorders Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 41: Italy, Muscle Wasting Disorders Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 42: Italy, Muscle Wasting Disorders Market, Segmentation By Disorder Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 43: Italy, Muscle Wasting Disorders Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 44: Spain, Muscle Wasting Disorders Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 45: Spain, Muscle Wasting Disorders Market, Segmentation By Disorder Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 46: Spain, Muscle Wasting Disorders Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 47: Eastern Europe, Muscle Wasting Disorders Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 48: Eastern Europe, Muscle Wasting Disorders Market, Segmentation By Disorder Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 49: Eastern Europe, Muscle Wasting Disorders Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 50: Russia, Muscle Wasting Disorders Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 51: Russia, Muscle Wasting Disorders Market, Segmentation By Disorder Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 52: Russia, Muscle Wasting Disorders Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 53: North America, Muscle Wasting Disorders Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 54: North America, Muscle Wasting Disorders Market, Segmentation By Disorder Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 55: North America, Muscle Wasting Disorders Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 56: USA, Muscle Wasting Disorders Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 57: USA, Muscle Wasting Disorders Market, Segmentation By Disorder Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 58: USA, Muscle Wasting Disorders Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 59: Canada, Muscle Wasting Disorders Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 60: Canada, Muscle Wasting Disorders Market, Segmentation By Disorder Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 61: Canada, Muscle Wasting Disorders Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 62: South America, Muscle Wasting Disorders Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 63: South America, Muscle Wasting Disorders Market, Segmentation By Disorder Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 64: South America, Muscle Wasting Disorders Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 65: Brazil, Muscle Wasting Disorders Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 66: Brazil, Muscle Wasting Disorders Market, Segmentation By Disorder Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 67: Brazil, Muscle Wasting Disorders Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 68: Middle East, Muscle Wasting Disorders Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 69: Middle East, Muscle Wasting Disorders Market, Segmentation By Disorder Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 70: Middle East, Muscle Wasting Disorders Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 71: Africa, Muscle Wasting Disorders Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 72: Africa, Muscle Wasting Disorders Market, Segmentation By Disorder Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 73: Africa, Muscle Wasting Disorders Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 74: Pfizer Inc. Financial Performance
  • Table 75: F. Hoffmann-La Roche Ltd. Financial Performance
  • Table 76: Roche Holding AG  Financial Performance
  • Table 77: Novartis AG Financial Performance
  • Table 78: Sanofi Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Figure 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Figure 3: Global Muscle Wasting Disorders Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 4: Global Muscle Wasting Disorders Market, Segmentation By Disorder Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 5: Global Muscle Wasting Disorders Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 6: Global Muscle Wasting Disorders Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 7: Global Muscle Wasting Disorders Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 8: Asia-Pacific, Muscle Wasting Disorders Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 9: Asia-Pacific, Muscle Wasting Disorders Market, Segmentation By Disorder Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 10: Asia-Pacific, Muscle Wasting Disorders Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 11: China, Muscle Wasting Disorders Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 12: China, Muscle Wasting Disorders Market, Segmentation By Disorder Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 13: China, Muscle Wasting Disorders Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 14: India, Muscle Wasting Disorders Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 15: India, Muscle Wasting Disorders Market, Segmentation By Disorder Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 16: India, Muscle Wasting Disorders Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 17: Japan, Muscle Wasting Disorders Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 18: Japan, Muscle Wasting Disorders Market, Segmentation By Disorder Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 19: Japan, Muscle Wasting Disorders Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 20: Australia, Muscle Wasting Disorders Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 21: Australia, Muscle Wasting Disorders Market, Segmentation By Disorder Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 22: Australia, Muscle Wasting Disorders Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 23: Indonesia, Muscle Wasting Disorders Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 24: Indonesia, Muscle Wasting Disorders Market, Segmentation By Disorder Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 25: Indonesia, Muscle Wasting Disorders Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 26: South Korea, Muscle Wasting Disorders Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 27: South Korea, Muscle Wasting Disorders Market, Segmentation By Disorder Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 28: South Korea, Muscle Wasting Disorders Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 29: Western Europe, Muscle Wasting Disorders Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 30: Western Europe, Muscle Wasting Disorders Market, Segmentation By Disorder Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 31: Western Europe, Muscle Wasting Disorders Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 32: UK, Muscle Wasting Disorders Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 33: UK, Muscle Wasting Disorders Market, Segmentation By Disorder Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 34: UK, Muscle Wasting Disorders Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 35: Germany, Muscle Wasting Disorders Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 36: Germany, Muscle Wasting Disorders Market, Segmentation By Disorder Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 37: Germany, Muscle Wasting Disorders Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 38: France, Muscle Wasting Disorders Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 39: France, Muscle Wasting Disorders Market, Segmentation By Disorder Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 40: France, Muscle Wasting Disorders Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 41: Italy, Muscle Wasting Disorders Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 42: Italy, Muscle Wasting Disorders Market, Segmentation By Disorder Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 43: Italy, Muscle Wasting Disorders Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 44: Spain, Muscle Wasting Disorders Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 45: Spain, Muscle Wasting Disorders Market, Segmentation By Disorder Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 46: Spain, Muscle Wasting Disorders Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 47: Eastern Europe, Muscle Wasting Disorders Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 48: Eastern Europe, Muscle Wasting Disorders Market, Segmentation By Disorder Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 49: Eastern Europe, Muscle Wasting Disorders Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 50: Russia, Muscle Wasting Disorders Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 51: Russia, Muscle Wasting Disorders Market, Segmentation By Disorder Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 52: Russia, Muscle Wasting Disorders Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 53: North America, Muscle Wasting Disorders Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 54: North America, Muscle Wasting Disorders Market, Segmentation By Disorder Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 55: North America, Muscle Wasting Disorders Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 56: USA, Muscle Wasting Disorders Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 57: USA, Muscle Wasting Disorders Market, Segmentation By Disorder Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 58: USA, Muscle Wasting Disorders Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 59: Canada, Muscle Wasting Disorders Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 60: Canada, Muscle Wasting Disorders Market, Segmentation By Disorder Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 61: Canada, Muscle Wasting Disorders Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 62: South America, Muscle Wasting Disorders Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 63: South America, Muscle Wasting Disorders Market, Segmentation By Disorder Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 64: South America, Muscle Wasting Disorders Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 65: Brazil, Muscle Wasting Disorders Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 66: Brazil, Muscle Wasting Disorders Market, Segmentation By Disorder Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 67: Brazil, Muscle Wasting Disorders Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 68: Middle East, Muscle Wasting Disorders Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 69: Middle East, Muscle Wasting Disorders Market, Segmentation By Disorder Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 70: Middle East, Muscle Wasting Disorders Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 71: Africa, Muscle Wasting Disorders Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 72: Africa, Muscle Wasting Disorders Market, Segmentation By Disorder Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 73: Africa, Muscle Wasting Disorders Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 74: Pfizer Inc. Financial Performance
  • Figure 75: F. Hoffmann-La Roche Ltd. Financial Performance
  • Figure 76: Roche Holding AG  Financial Performance
  • Figure 77: Novartis AG Financial Performance
  • Figure 78: Sanofi Financial Performance
Forecasting Till 2030: Opportunities And Strategies In The Global Value Based Care Payment Market – Includes Value Based Care Payment Market Analysis
Read More
How Will The Nuclear Medicine Market Grow In 2022?
Read More
What Is The Pediatric Imaging Market Overview In 2022?
Read More
Latest Healthcare Technology Management Market Growth Study 2022-2026 By The Business Research Company
Read More
The Business Research Company offers the hospital acquired infection control market research report 2022 with industry size, share, segments and market growth
Read More
The Business Research Company offers the multiplex assays market research report 2022 with industry size, share, segments and market growth
Read More
The Business Research Company offers the healthcare it consulting market research report 2022 with industry size, share, segments and market growth
Read More
The Business Research Company offers the renal biomarkers market research report 2022 with industry size, share, segments and market growth
Read More
Anorectal Disorders Treatment Global Market Report 2024 – By Treatment (Drugs, Surgery, Other Treatment), By Disease (Diarrhea, Hemorrhoid, Abscesse, Fistula, Itching, Other Disease), By Route Of Administration (Oral, Parenteral, Rectal, Other Route of administration), By End-Users (Hospitals, Specialty Clinics, Other End-Users) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Optic Nerve Disorders Treatment Global Market Report 2024 – By Treatment Type (Steroidal Therapy, Immunomodulators therapy, Other Treatment Types), By Indication (Glaucoma, Optic Neuritis, Optic Neuropathy, Congenital Optic Atrophy, Other Indications), By End User (Hospitals, Ambulatory Surgery Centers, Clinics, Other End Users) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Bleeding Disorders Treatment Global Market Report 2024 – By Treatment (Desmopressin (DDAVP), Hormone Replacement Therapy, Contraceptives, Anti-Fibrinolytic or Clot-Stabilizing Drugs, Fibrin Sealants, Drugs Applied To Cuts, Pipeline Analysis), By Disease Type (Hemophilia A, Hemophilia B, Von willebrand disease, Liver disease, Other Disease Types), By End User (Hospitals, Clinics, Specialty Clinics, Research Institutes, Other End Users) – Market Size, Trends, And Global Forecast 2024-2033
View Report
HPV Associated Disorders Global Market Report 2024 – By Indication (Cervical Intraepithelial Neoplasia (CIN), Cervical Cancer, Anal Intraepithelial Neoplasia (AIN), Anal Cancer, Genital Warts, Other Indications), By Therapy (Prevention, Treatment), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Generic Musculoskeletal Disorders Drugs Global Market Report 2024 – By Treatment Type (Medication, Therapy, Surgery, Other Treatment Types), By Disorder Type (Osteoarthritis, Rheumatoid Arthritis, Spondylarthritis, Juvenile Idiopathic Arthritis, Psoriatic Arthritis, Fibromyalgia, Other Disorder Types), By Route of Administration (Oral, Parenteral, Other Routes), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Drug Store, Online Pharmacy) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Headache Disorders Global Market Report 2024 – By Type (Migraine, Tension-Type Headache, Cluster Headache, Medication-Overuse Headache, Other Types), By Treatment (Medication, Heat Therapy, Diet Changes, Acupuncture, Oxygen Therapy), By Diagnosis (Complete Blood Count, Skull X-Rays, Sinus X-Rays, CT Scan, Magnetic Resonance Imaging (MRI)), By Route Of Administration (Oral, Parenteral, Other Route Of Administrations), By End-User (Hospitals, Specialty Clinics, Homecare, Other End-Users) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Myeloproliferative Disorders Drugs Global Market Report 2024 – By Type (Primary Myelofibrosis, Polycythemia Vera (PV), Essential Thrombocythemia (ET), Chronic Eosinophilic Leukemia Or Hyper eosinophilic Syndrome (HES), Systemic Masto cytosis (SM)), By Drug Type (JAK2 Inhibitors, Anti-Neoplastics, Demethylation Agents, Imatinib Mesylate, Other Drug Types), By Route Of Administration (Oral, Parenteral, Other Routes Of Administration), By Distribution Channel (Hospital Pharmacy, Retail Stores, Drug Stores) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Autism Spectrum Disorders Treatment Global Market Report 2024 – By Drug Therapy (Antipsychotic Drugs, SSRIs or Antidepressants, Stimulants, Sleep Medications, Other Drug Therapies), By Treatment Approach (Behavioral Approaches, Early Intervention, Medication), By Application (Autistic Disorder, Asperger Syndrome, Pervasive Developmental Disorder, Other Applications), By Distribution Channel (Hospital Pharmacies, Drug Stores and Retail Pharmacies, Online Pharmacies) – Market Size, Trends, And Global Forecast 2024-2033
View Report

Frequently Asked Questions

What is the definition of the muscle wasting disorders market?

Muscle wasting disorders, or muscle atrophy or muscle wasting, refer to a condition characterized by a diverse group of conditions that cause the progressive loss of muscle mass and strength. This can occur as a result of various factors, including disuse, aging, malnutrition, neurodegenerative diseases, and certain medical conditions. For further insights on the muscle wasting disorders market, request a sample here

How will the muscle wasting disorders market drivers and restraints affect the muscle wasting disorders market dynamics? What forces will shape the muscle wasting disorders industry going forward?

The muscle wasting disorders market major growth driver - sedentary lifestyle trends fueling growth in the muscle wasting disorders market. For further insights on the muscle wasting disorders market, request a sample here

What is the forecast market size or the forecast market value of the muscle wasting disorders market ?

The muscle wasting disorders market size has grown rapidly in recent years. It will grow from $12.91 billion in 2023 to $15.06 billion in 2024 at a compound annual growth rate (CAGR) of 16.6%. The growth in the historic period can be attributed to increasing aging population, rising incidence of chronic diseases, advancements in research and development, increased awareness of early diagnosis, emerging therapeutic approaches. The muscle wasting disorders market size is expected to see rapid growth in the next few years. It will grow to $26.11 billion in 2028 at a compound annual growth rate (CAGR) of 14.8%. The growth in the forecast period can be attributed to regulatory support, patient advocacy initiatives, healthcare infrastructure development, globalization of clinical trials, personalized medicine approaches. Major trends in the forecast period include telemedicine adoption, technological advancements in diagnostics, product innovation, collaborations and partnerships, advancements in therapeutics, research on molecular mechanisms, biopharmaceutical innovation. For further insights on the muscle wasting disorders market, request a sample here

How is the muscle wasting disorders market segmented?

The muscle wasting disorders market is segmented
1) By Treatment Type: Medications, Physical Therapy, Nutritional Therapy, Surgery, Gene Therapy, Other Treatment Types
2) By Disorder Type: Muscular Dystrophy, Amyotrophic Lateral Sclerosis (ALS), Other Disorder Types
3) By End-User: Hospitals, Rehab Centers, Specialty Clinics, Other End-UsersFor further insights on the muscle wasting disorders market, request a sample here

Which region has the largest share of the muscle wasting disorders market? What are the other regions covered in the report?

North America was the largest region in the muscle wasting disorder market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the muscle wasting disorders market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on the muscle wasting disorders market, request a sample here.

Who are the major players in the muscle wasting disorders market?

Major companies operating in the muscle wasting disorders market report are Pfizer Inc., F. Hoffmann-La Roche Ltd., Roche Holding AG , Novartis AG, Sanofi, GlaxoSmithKline (GSK), Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals, Acceleron Pharma Inc., Biogen Inc., Santhera Pharmaceuticals Holding AG, Mitsubishi Tanabe Pharma, Nippon Shinyaku Co. Ltd. (NS Pharma, Inc.), Sarepta Therapeutics Inc., PTC Therapeutics Inc., Ionis Pharmaceuticals Inc., Axogen, Inc., FibroGen Inc., Cytokinetics Incorporated, Italfarmaco S.p.A., Scholar Rock, Bellerophon Therapeutics, Akashi Therapeutics, aTyr Pharma, Metabolic Solutions Development Company, Synaptogenix , MyoKardia, Inc., MyoTherix Inc. For further insights on the muscle wasting disorders market, request a sample here.

What are the key trends in the muscle wasting disorders market?

Major trend in the muscle wasting disorders market - innovative advancements in the muscle wasting disorders market . For further insights on the muscle wasting disorders market, request a sample here.

What are the major opportunities in the muscle wasting disorders market? What are the strategies for the muscle wasting disorders market?

For detailed insights on the major opportunities and strategies in the muscle wasting disorders market, request a sample here.

How does the muscle wasting disorders market relate to the overall economy and other similar markets?

For detailed insights on muscle wasting disorders market's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the muscle wasting disorders industry?

For detailed insights on the mergers and acquisitions in the muscle wasting disorders industry, request a sample here.

What are the key dynamics influencing the muscle wasting disorders market growth? SWOT analysis of the muscle wasting disorders market.

For detailed insights on the key dynamics influencing the muscle wasting disorders market growth and SWOT analysis of the muscle wasting disorders industry, request a sample here.